Studies From University Of Wisconsin Reveal New Findings On Non-Melanoma Skin Cancer

Polo-like kinase 1 (Plk1) is becoming an increasingly attractive target for cancer management. Plk1 has been shown to be overexpressed in a variety of cancers; however its role in skin cancers is not well-understood, scientists in the United States report.